ATALANTE
Atezolizumab vs Placebo Phase III Study in Late Relapse Ovarian Cancer Treated With Chemotherapy+Bevacizumab
GINECO
SENTICOL III
International Validation Study of Sentinel Node Biopsy in Early Cervical Cancer
Trial Number
NCT03386734 (ClinicalTrials.gov Identifier)Contact Person
Status
Disease Site
Lead Cooperative Group
Participating Groups
GCIG Number
PAOLA-1
Platine, Avastin and Olaparib in 1st line Ovarian Cancer
Trial Number
NCT02477644 (ClinicalTrials.gov ID)Contact Person
Status
Disease Site
Lead Cooperative Group
Participating Groups
GCIG Number
EWOC-1
Carboplatin +/- Paclitaxel in Vulnerable Elderly Patients With Stage III-IV Advanced Ovarian Cancer
Trial Number
NCT02001272 (ClinicalTrials.gov Identifier)Contact Person
Status
Disease Site
Lead Cooperative Group
Participating Groups
GCIG Number
ALIENOR-GINECO-OV222
Efficacy and Safety of Bevacizumab (Avastin) Combined to Weekly Paclitaxel Followed by Bevacizumab (Avastin) Alone in Patients With Relapsed Ovarian Sex-cord Stromal Tumours